Tate & Lyle plc, together with its subsidiaries, engages in the provision of ingredients and solutions to the food, beverages, and other industries in North America, Asia, Middle East, Africa, Latin America, and Europe. Its portfolio includes sweeteners, fibres, stabilisers and functional systems, hydrocolloids, and starches, proteins, and functional flours. The company's products are used in beverages, dairy, soups, sauces and dressings, bakery and snacks, confectionery, household, clinical nutrition, industrial, meat and seafood, and personal care applications. The company has a strategic collaboration with BioHarvest Sciences Inc. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.

Currency in GBP	2026
Operating Income	61.00 Million
Income Before Tax	32.75 Million
Income Tax Expense	8.25 Million
Net Income	24.25 Million
Eps	0.06
Epsdiluted	0.05
Weighted Average Shs Out	442.30 Million
Weighted Average Shs Out Dil	447.20 Million
Depreciation And Amortization	43.00 Million
Interest Expense	14.25 Million
Ebit	47.00 Million
Interest Income	2.00 Million
Net Interest Income	-12.25 Million
Premiums Earned	N/A
Policyholder Benefits	N/A
Period	Q4
Ebitda	104.00 Million
Net Cash Provided By Operating Activities	N/A
Source	yahoo

Tate & Lyle plc Annual Reports (10-K)